Portola Pharma (PTLA) Reports Q3 Loss of $1.64/Share

Portola Pharma (NASDAQ: PTLA) reported Q3 EPS of ($1.64), may not compare to the analyst estimate of ($1.10).

For earnings history and earnings-related data on Portola Pharma (PTLA) click here.

You May Also Be Interested In

• IMF chief says global economy weathered Iran war shock well
• Netflix engagement data points to stronger results ahead, Wolfe says
• Rush Enterprises Inc. (RUSHA) PT Raised to $85 at UBS